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Abstract
AIM: To investigate the inhibitory action of diet-derived 
phenolic compound gallic acid (GA) against HCT-15 
colon cancer cells. 
METHODS: The antiproliferative effect of GA against 
colon cancer cells was determined by performing 
thiazolyl blue tetrazolium bromide (MTT) assay. The 
colony forming ability of GA treated colon cancer 
cells was evaluated using the colony forming assay. 
The cell cycle changes induced by GA in HCT-15 cells 
were analyzed by propidium iodide staining. Levels 
of reactive oxygen species (ROS) and mitochondrial 
membrane potential of HCT-15 exposed to GA was 
assessed using 2’,7’-dichlorfluorescein-diacetate and 
rhodamine-123 respectively, with the help of flow 
cytometry. Morphological changes caused by GA 
treatment in the colon cancer cells were identified by 
scanning electron microscope and photomicrograph 
examination. Apoptosis was confirmed using flow 
cytometric analysis of GA treated HCT-15 cells after 
staining with Yo-Pro-1.
RESULTS: MTT assay results illustrated that GA has an 
inhibitory effect on HCT-15 cells with IC50 value of 740 
µmol/L. A time-dependent inhibition of colony formation 
was evident with GA treatment. Cell cycle arrest was 
evident from the accumulation of GA treated HCT-15 
cells at sub-G1 phase (0.98 ± 1.03 vs  58.01 ± 2.05) 
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Basic Study
Gallic acid induced apoptotic events in HCT-15 colon cancer 
cells
estimates 93090 new cases and 49700 deaths due to 
colorectal cancer in the United States for 2015[4]. Colon 
cancer arises out of the conversion of the normal 
functioning colonic epithelium to adenomatous polyps. 
Its etiology is known to be a combination of hereditary, 
environmental, dietary factors and lack of physical 
activity[5]. Several anticancer agents were found 
to exert their effect by inducing apoptosis. Various 
lines of evidence suggest that apoptosis provides a 
protective mechanism against neoplasia by removing 
genetically damaged stem cells from the epithelium 
before they can undergo clonal expansion. Some of 
these anticancer agents were also found to occur in 
our diets. These diets include majorly flavonoids and 
phenolic compounds[6]. In this scenario, research 
communities explore more diet-derived compounds 
to treat colon cancer as the lining-epithelial cells are 
chronically exposed to these dietary agents[7]. 
Gallic acid is one such diet-derived phenolic sub-
stance being surveyed. GA is a 3,4,5-trihydroxyben-
zoic acid (C6H2(OH)3COOH), a type of phenolic organic 
compound found in many plants and food substances. 
The chemical structure is shown in the Figure 1. GA 
is found in free as well as part of hydrolyzable tannins 
and easily freed from gallotannins by oxidation. GA is 
a phytochemical in oak, Drosera, golden root, stinging 
nettle, Chinese mahogany and dietary substances like 
bearberry, blackberry, hot chocolate, common walnut, 
Indian gooseberry, raspberry, clove, vinegar, wine, 
witch hazel and green tea[8]. 
Previous studies have demonstrated a range 
of biological activities of GA, including anticancer, 
antioxidant and anti-inflammatory properties[9]. The 
various in vitro assays examining the anticancer 
property showed that the GA is active against several 
types of cancer cell lines[10]. Particularly, the studies 
showed that GA induced cell death in colon cancer 
lines COLO 205, HCT-15, HCT 116[11]. However, the 
mechanism induced by GA against colon cancer is not 
yet elucidated. Thus, this research proposes a study of 
the antiproliferative activity of GA as well as, intends to 
find the events associated with apoptotic effect of GA 
in HCT-15 colon cancer cells. 
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Figure 1  Chemical structure of gallic acid.
with increasing exposure time. Flow cytometric analysis 
of GA treated HCT-15 cells depicted early events 
associated with apoptosis like lipid layer breakage and 
fall in mitochondrial membrane potential apart from an 
increase in the generation of ROS which were in a time 
dependent manner. SEM and photomicrograph images 
of the GA-treated cells displayed membrane blebbing 
and cell shrinking characteristics of apoptosis. Further 
apoptosis confirmation by Yo-Pro-1 staining also 
showed the time-dependent increase of apoptotic cells 
after treatment.
CONCLUSION: These results show that GA induced 
ROS dependent apoptosis and inhibited the growth of 
colon cancer cells.
Key words: Gallic acid; Colon cancer; Apoptosis; Cell 
cycle; Reactive oxygen species; Lipid layer break 
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Core tip: This article describes the inhibitory effect 
of gallic acid (GA), against colon cancer cells. GA 
treatment suppressed the proliferation and colony 
formation of HCT-15 cells and the anti-cancerous 
effect of GA was found to follow reactive oxygen 
species dependent apoptosis. Early events associated 
with apoptosis like lipid layer breakage and fall in 
mitochondrial membrane potential were induced by GA 
treatment in HCT-15 cells along with cell cycle arrest. 
Further, morphological changes like membrane blebbing 
and cell shrinkage were seen in the colon cancer cells 
after GA. Therefore, our results propel the role of GA as 
a possible anticancer agent.
Subramanian AP, Jaganathan SK, Mandal M, Supriyanto 
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INTRODUCTION
Gastrointestinal (GI) diseases account for substantial 
morbidity, mortality and cost in both developed and 
developing countries. Gastrointestinal diseases refer 
to diseases involving the gastrointestinal tract[1]. The 
GI tract is essentially a long tube extending from 
the mouth to the anus with a number of specialized 
regions. Gastrointestinal cancers usually develop in 
the large intestine or the small intestine[2]. Colorectal 
cancer is a malignant tumor arising from the inner 
wall of large intestine, which is the third most common 
type of cancer[3]. The American Cancer Society’s 
MATERIALS AND METHODS
Chemicals 
The Roswell Park Memorial Institute medium 
(RPMI-1640) cell culture medium, fetal bovine serum 
(FBS), additional sources like sodium pyruvate, 
nonessential amino acids, L-glutamine, vitamin 
solution, penicillin and streptomycin were purchased 
from Life Technologies, Inc., Grand Island, United 
States. Reagents like as 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl-tetrazolium-bromide (MTT), propidium 
iodide, mercury orange, RNase and GA were obtained 
from Sigma-Aldrich (United States). Supplementary 
stains such as merocyanine - 540 and YO-PRO-1 were 
acquired from Invitrogen Inc, United States.
Cell culture
Human colorectal adenocarcinoma cell line HCT-15 
(Organ: Colon, Disease: Colorectal adenocarcinoma; 
Organism: Human; procured from National Centre 
for Cell Science, Pune, India) was grown in RPMI 
medium, while 10% FBS, sodium pyruvate, penicillin, 
L-glutamine, nonessential amino acids and vitamin 
solution was given as supplements. Adherent 
monolayer cultures of HCT-15 were preserved in T-25 
flasks and incubated at 37 ℃ in 5% carbon dioxide 
(CO2). The cultures were free of mycoplasma and 
maintained no longer than 12 wk after recovery from 
frozen stocks.
Cell viability assay
Cell numbers or cell proliferation inhibition by GA was 
determined by thiazolyl blue tetrazolium bromide (MTT) 
assay. In brief, colon cancer cells were trypsinized, 
counted and 1000 cells were seeded per well in 96-well 
plate. The subsequent day, 100 µL of the medium 
containing the preferred concentration of GA was 
added to the appropriate wells. The cells were then 
maintained at 37 ℃ in 5% CO2 for the desired length 
of time. The untreated cells kept for 72 h was used as 
control for this experiment. At this moment, 100 µL of 
(5 mg/mL) MTT reagent was added to each well, and 
the plate was sustained at 37 ℃ in the incubator for 2 
h. After aspirating the supernatant, 200 µL of dimethyl 
sulfoxide was added to each well to solubilize the 
formazan crystals formed in viable cells. The optical 
density was spectrophotometrically measured at 570 
nm using enzyme-linked immunosorbent assay plate 
reader[12]. 
Colony forming assay
In order to assess the colony forming ability of GA 
treated colon cancer cells, the colony formation assay 
was executed. The cultured HCT-15 cells were treated 
with GA at a concentration of 740 µmol/L for definite 
time periods of 12 h, 24 h, 48 h and collected by 
trypsinization. The cells were counted and seeded 
again in triplicate on a 6-well tissue culture plate with 
3000 cells/well. Following 15-d incubation at 37 ℃, 
colonies were stained with 0.5% crystal violet in 
methanol and the number of colonies was counted[13]. 
Control used in this experiment was untreated cells 
kept for 72 h. For all the experiments performed 
below, control cells remained untreated and kept for 
the same duration as the longest time point of the 
respective experiment.
Cell cycle analysis
Cell cycle analysis is an exceptional type of test that 
involves the flow cytometry and the fluorescent 
propidium dye and distinguishes the different phases 
of the cell cycle. The sub-G1 fraction of the cell cycle 
was used as a measure of the apoptotic cells. After 
the appropriate treatment with GA, HCT-15 cells were 
washed with phosphate-buffered saline (PBS), then 
re-suspended in 50 µg/mL of propidium iodide stain 
containing 0.1% sodium citrate with 0.1% Triton 
X-100 for 20 min at 4 ℃. Analysis was performed in 
linear amplification mode in case of cell cycle analysis 
using FACScan; Becton Dickinson Immunocytometry 
Systems. Remaining experiments of flow cytometry 
were performed in the logarithmic amplification mode 
unless otherwise stated[14]. 
Determination of mitochondrial membrane potential
MMP (ΔΨm) levels of GA treated HCT-15 cells were 
measured by the rhodamine-123 fluorescent dye. 
The HCT-15 colon cancer cells were treated with GA 
(740 µmol/L) for different time points. Then cells were 
harvested and re-suspended in 1 mL of rhodamine-123 
(5 µg/mL) for 1 h and maintained at 37 ℃. The 
intensity of fluorescence from rhodamine-123 was 
measured by flow cytometry[12]. Obtained fluorescence 
values were normalized with respect to control as 
100%.
Detection of membrane lipid organization
The lipid bilayer breaks when the drugs induce an 
antiproliferative effect on the cancerous cells. To 
estimate the lipid layer breakage the fluorescent dye 
merocyanine-540 is used. The cultured HCT-15 cells 
were treated with GA at concentration of 740 µmol/L 
for different time points. Cells were harvested and re-
suspended in 1 mL of merocyanine-540 (10 µg/mL) 
for 15 min at 37 ℃. The intensity of fluorescence was 
measured by flow cytometry[13]. 
Estimation of ROS generation
GA treated HCT-15 cells (740 µmol/L) were harvested 
using trypsin/EDTA and re-suspended in PBS. 
Working solution (20 µmol/L) of Dichlorofluorescein-
diacetate (DCFH-DA) was directly added to the cells 
and then it was incubated at 37 ℃ for 15 min. DCFH-
DA was cleaved by the intracellular nonspecific 
esterase to form DCFH. DCFH are oxidized by ROS 
to form the fluorescent compound DCF. Cells were 
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triplicates). The data were analyzed using Instat software 
(GraphPad Prism, San Diego, CA). The statistical signi-
ficance was found using one-way analysis of variance.
RESULTS
Antiproliferative activity of gallic acid
The antiproliferative effect of GA on the cancer cells 
was assessed by MTT assay. The cell viability assay 
was performed on the GA treated cells after 72 h of 
treatment. GA inhibited the growth of HCT-15 colon 
cancer cells in a dose-dependent manner. The HCT-15 
cell growth were inhibited significantly with an IC50 of 
around 740 µmol/L (Figure 2). However, the growth 
of GA treated HCT-15 cells were fairly affected even at 
higher concentrations. Statistical analysis showed that 
GA treatment results in significant inhibition (P < 0.05) 
compared with untreated control cells at 200 µmol/L 
for HCT-15 cells (Figure 2).
Colony forming assay
The HCT-15 cells found to form 192 colonies after 12 h 
treatment with GA (740 µmol/L). The colony numbers 
reduced with increase in the period of exposure to GA. 
The GA treated HCT-15 cells showed a maximum of 
155 and 110 colonies after 24 h and 48 h of treatment 
respectively. In contrast, the untreated HCT-15 cells 
were found to produce a maximum of 210 colonies 
after 48 h. This is graphically represented in Figure 
3. The figure depicts the time-dependent inhibition 
of colony formation by GA on the colon cancer cells. 
There was a significant reduction (P < 0.05) in the 
number of colonies formed under the various time 
intervals examined when compared with corresponding 
untreated cells (Figure 3).
Cell cycle analysis
The effect of GA on the different phases of cell cycle 
washed before re-suspending in PBS and kept on ice 
immediately before analyzing by flow cytometry[12]. 
The fluorescence intensity of DCF was measured and 
correlated with the ROS generated in the GA treated 
colon cancer cells.
Yo-Pro-1 staining
Yo-Pro-1 staining helps in the analysis of apoptotic 
cells without interfering cell viability. The stain targets 
the nucleic acids of the cells and emits a green 
fluorescence that is detected. The HCT-15 cells after 
treatment with GA (740 µmol/L), were seeded in 
the cell pellets and mixed with 1 µmol/L Yo-Pro-1 
for 20 min at room temperature. After incubation, 
the fluorescent intensity was measured using flow 
cytometry[14].
Morphological assessment after GA treatment
Fixed amount of HCT-15 cells were seeded in a 
sterilized glass slide and incubated for 24 h. GA at a 
concentration of 740 µmol/L was added for 72 h time 
interval. After incubation, cells were harvested by 
using trypsin/EDTA and centrifuged for 5 min at room 
temperature. Then the supernatant was decanted 
and pellet was dried. Pellet was treated with 2.5% 
glutaraldehyde in distilled water for 45 min in hybrid 
oven shaker at 37 ℃. Cells were washed thrice with 
PBS for 5 min and then dehydrated by ethyl alcohol 
of different concentration (30%, 50%, 70%, 95% 
and 100%) for 5-10 min. Cell fixation was done with 
hexamethyl disilazane and the sample was taken for 
scanning electron microscope analysis. As well as the 
photomicrograph images of HCT-15 cells were also 
acquired using light microscope.
Statistical analyses
The results are expressed as the mean ± SD and 
repeated at least three independently (biological 
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Figure 2  Cell proliferation inhibition by gallic acid of colon cancer cells. Human colorectal carcinoma HCT-15 cells grown in 96-well plate were treated with 
various concentration of gallic acid (GA) (0-1500 µmol/L) for 72 h. Percentage of mean cell viability along-with the SD is indicated (n = 3). Mean differences are 
significant compared with untreated control cells (P < 0.05 vs untreated control cells). Statistical analysis showed that GA treatment results in significant inhibition (aP 
< 0.05) compared with untreated control cells starting at 200 µmol/L for HCT-15 cells. Data represents mean ± SD.
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of HCT-15 cells was estimated for time intervals of 
24 h, 48 h and 72 h. The mean percentage of cells at 
various phases like sub-G1, G0/G1, S and G2/M phases 
are tabulated in Table 1. The Table showed an increase 
in the sub-G1 phase arrest from 0.98% (control) to 
58.01% after 72 h. Statistical analysis of the sub-G1 
column indicated a significant increase (P < 0.05) 
of cells in the sub-G1 phase. Besides this, the time 
dependency on the cell cycle arrest induced by GA 
treatment on HCT-15 cells was also inferred.
Mitochondrial membrane potential after GA treatment
The HCT-15 cells were treated with GA of concentration 
at 740 µmol/L at various time intervals (12 h and 24 h) 
and then stained with rhodamine-123 dye. The Figure 
4 shows the mean fluorescent intensity of the control 
and GA treated HCT-15 cells. The untreated HCT-15 
cells are considered to have maximum fluorescent 
intensity. In contrast, the normalized percentage of 
mean fluorescent intensity decreased to 81 ± 0.577 
and 61 ± 1.528 compared to the untreated cells (100% 
after 24 h) after 12 h and 24 h of GA treatment 
respectively. There was also a statistically significant 
reduction (P < 0.05) of potential at the estimated 
intervals compared to untreated cells (Figure 4).
Membrane Lipid organization after GA treatment
The HCT-15 cells were treated with GA (740 µmol/L) at 
intervals of 12 h and 24 h. The fluorescent intensities 
detected from the merocyanine-540 stained cells 
were measured using flow cytometry. The untreated 
HCT-15 cells displayed a maximum mean fluorescence 
intensity at 40 after 24 h. The GA treated HCT-15 
cells showed maximum intensity at 62 and 68 after 
12 h and 24 h respectively. The maximum mean 
fluorescence intensities of the GA treated cells are 
given in Figure 5. It is evident from the above results 
that the GA treated HCT-15 cells displayed an increase 
in the lipid layer breaks with an increase in exposure 
time. 
ROS generation after GA treatment
The ROS generated by the HCT-15 cells after GA 
(740 µmol/L) treatment was estimated at various 
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Figure 3  Colony inhibitory activity of gallic acid against colon cancer 
cells. After various incubation periods of gallic acid (GA) treatment, colonies 
formed were stained with 0.5% crystal violet and counted, and percentage of 
survival was calculated by normalizing the values. Data reported is the mean 
± SD from three different observations. Mean differences are significant at 12 
h, 24 h and 48 h compared with untreated control cells (P < 0.05 vs untreated 
control cells).
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Figure 4  Effects of gallic acid on MMP (ΔΨm) in HCT-15 cells. Human 
colorectal carcinoma (HCT-15) cells were treated with GA for specified time-
periods and then mitochondrial membrane potential were determined using 
rhodamine-123 by flow cytometry. Mean differences are significant at 12 h and 
24 h compared with untreated control cells (P < 0.05 vs untreated control cells).
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Figure 5  Lipid layer break provoked by gallic acid. HCT-15 cells were 
treated with gallic acid (GA) and evaluated using merocyanine-540 to quantify 
the lipid layer breaks (LLBs). The fluorescence intensity was estimated using 
flow cytometry. Data is representative of three independent experiments, mean 
differences are significant at 12 h and 24 h compared with untreated control 
cells (P < 0.05 vs untreated control cells).
Table 1  Percentage distribution of HCT-15 cells after gallic 
acid treatment among various cell cycle stages
Time (h) Sub G11 G0/G1 S G2/M
Control   0.98 ± 1.03 42.82 ± 3.70 8.03 ± 2.37 40.07 ± 2.81
24   6.80 ± 2.73 32.50 ± 2.04 3.89 ± 1.78 42.25 ± 4.52
48 27.67 ± 1.56 25.51 ± 1.68 2.50 ± 3.54 29.12 ± 1.75
72 58.01 ± 2.05 12.89 ± 2.56 3.52 ± 1.09 15.26 ± 3.08
1Mean differences are significant at P < 0.05. Data represents mean ± SD.
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time intervals such as 24 h, 48 h and 72 h. The ROS 
generated by the cells oxidized the DCFH-DA to 
dichlorofluoresin and the fluorescence emitted was 
measured. The fluorescent intensity obtained by flow 
cytometry is shown in the Figure 6. The maximum 
mean fluorescent intensity was found to be 112, 140, 
and 182 during 24 h, 48 h and 72 h respectively. 
Whilst, the maximum intensity of control HCT-15 cells 
was about 98 after 72 h. Moreover, the differences 
in the ROS levels at various hours examined were 
significant (Figure 6). The ROS generation from the 
HCT-15 cells was increased by GA treatment with 
respect to the increase in time of exposure. 
Morphological assessment of GA treated cells
Photomicrograph images of untreated and GA treated 
colon cancer cells (72 h) were acquired. The obtained 
images are shown in Figure 7A. In comparison to 
the untreated cells, the characteristic changes such 
as membrane blebbing and cell shrinkage are visible 
in the GA treated cells. These changes embrace the 
induction of apoptosis after GA treatment. Along with 
the digital microscopic image obtained, the HCT-15 
cells were also examined with a scanning electron 
microscope to provide topographical or morphological 
images with high resolution. The images of untreated 
HCT-15 cells and GA treated HCT-15 cells (72 h) are 
given in the Figure 7B. It is evident from the images 
that the GA treated cells showed typical signs of 
apoptosis like membrane blebbing and shrinkage. 
In contrast, normal cells did not show any marked 
shrinkage. Hence, the microscopic images further 
corroborated the signs of apoptosis induced by GA. 
The images given the Figure 7 is representative of 
three independent experiments. 
Yo-Pro-1 staining
The HCT-15 cells were treated with GA (740 µmol/L) 
at various intervals of time such as 48 h and 72 h. The 
green fluorescence emitted by the Yo-Pro-1 stain from 
the GA treated HCT-15 cells is measured using flow 
cytometry. The result of fluorescence detected from 
the colon cancer cell line is given in the Figure 8. The 
maximum mean fluorescence intensity of GA treated 
HCT-15 cells at M2 phase was found to be 25.32 and 
54.61 after 48 h and 72 h. In contrast, the maximum 
mean fluorescence intensity of control cells at M2 
phase was found to be 7.75 after 72 h. 
DISCUSSION
Diet is thought to have a major role in the etiology 
of colorectal cancer. Similar studies also proved that 
a phytochemical-rich diet, which is absorbed by the 
body from fruit and vegetable sources, could decrease 
the risk of developing colon cancer[15]. Previous work 
revealed various biological properties of phenolic 
content in the diet that we consume regularly. These 
phenolic compounds are commonly known for their 
anticancer property. The phenolic compound GA 
exhibited an antiproliferative effect on the HCT-15 colon 
cancer cell lines in a dose dependent manner which 
was similar to the effect of GA on the human hepatoma 
SMMC-7721 cell proliferation in in vitro condition[16]. 
Hence it can be inferred that GA treatment led to lysis 
of HCT-15 cells with increasing concentrations either 
by apoptosis or necrosis. Cell growth was inhibited 
significantly with an IC50 of around 740 µmol/L and 
this was parallel to the results obtained in the recently 
conducted study of the antiproliferative effect of GA on 
HCT-15 by Yumnam et al[17]. In a particular study, the 
oral consumption of six cups of black tea resulted in 
344 mg GA[18]. However, about 25 mg of GA is enough 
to yield about 750 µmol/L in the colonic volume of 200 
mL. This shows that the IC50 obtained in our study lies 
within the range of biological availability. Moreover, 
the effect of GA on intestinal epithelial cells (IEC) was 
investigated. It was seen that about 85% of cells 
were viable when treated with 3.5 mmol/L showing 
that the GA treatment was non-toxic to normal cells 
(results not shown). These results depict that the 
phenolic compound GA has insignificant inhibitory 
activity against colon cancer cells at even a very high 
concentration. 
Colony formation is one of the characteristic 
features of cancer cells, which was inhibited by GA 
treatment in a time dependent manner which is alike 
to the results obtained by the clonogenic assay on the 
GA treated A549 human lung adenocarcinoma cells[19]. 
The cancer cells grow rapidly and multiply uncon-
trollably therefore, one of the fundamental features 
expected to be present in the anticancer drug, is 
the ability of the drug to affect the cell proliferation. 
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Figure 6  Gallic acid induced reactive oxygen species generation. 
HCT-15 cells were cultured in the presence or absence of gallic acid (GA) for 
the specified time points. DCFH-DA fluorescence intensity was detected by 
using flow cytometry. Data represented is the maximum of three independent 
experiments. Mean differences are significant at 24 h, 48 h and 72 h compared 
with untreated control cells (P < 0.05 vs untreated control cells). 
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Nevertheless, GA is found to evidently affect the colony 
formation of HCT-15 cells. The morphological changes 
such as cell shrinkage and membrane blebbing was 
visible in the colon cancer cells exposed to GA, which 
agrees to the earlier experimentation of Yumnam et 
al[17] on the GA treated HCT-15 cells[17]. These cellular 
changes witnessed in GA treated cells are similar to 
characteristic changes in the cellular organelles during 
apoptosis[20]. Thus, the microscopic examinations show 
GA induces apoptosis in HCT-15 cells. 
In normal biological systems, ROS is continuously 
generated and eliminated as well as plays an important 
role in driving various regulatory pathways. The cell 
balances the generation of ROS thereby controlling it. 
However, abundant generation of ROS during oxidative 
stress may affect the lipids, cellular proteins. In our 
study, GA promoted the generation of ROS in the 
colon cancer cell lines depending on the duration of 
exposure, which is analogous to the antiproliferative 
effect of GA against MiaPaCa-2 human pancreatic 
cancer cells[21]. As the raise in ROS generation is said to 
cause apoptosis through extrinsic or intrinsic pathways 
in the cancer cells, the promotion of ROS generation in 
GA treated HCT-15 cells supports the antiproliferative 
effect of GA[22]. Other significant pro-apoptotic event 
is lipid layer breakage, which is said to favor the 
interaction between the drug tested and the other 
cell organelles Lipid layer breakage was enhanced 
by GA treatment in the colon cancer cell lines. This 
finding is supported by GA-induced lipid layer breaks 
in the HSC-2 human oral cancer cells[23]. The lipid 
layer breakage is an optimistic event that favor the 
interaction between the drug tested and the other 
cell organelles[24]. Hence, the effect of GA on the lipid 
layer of HCT-15 cells may be related to the apoptosis-
inducing ability of GA. A great increase in ROS has 
been associated with reduced cancer cell proliferation 
by induction of cell cycle arrest. The GA treatment 
caused a time-dependent cell cycle arrest at the sub-G1 
phase in HCT-15 cells, which was similar to activity of 
GA on HL-60 human leukemia cells[25]. However, the 
Sub-G1 phase is related to measurement of apoptosis 
or programmed cell death[13]. During apoptosis, the 
DNA is degraded and the content becomes less than 
that the DNA content in healthy cells undergoing 
cell cycle[26]. The increase in the amount of cells at 
Sub-G1 phase infers that GA treatment of HCT-15 cells 
may be ascribed to programmed cell death in a time 
dependent manner.
Mitochondrial malfunction is another key event 
that occurs during apoptosis. Mitochondrial membrane 
potential (MPP) of GA treated cells showed decreasing 
intensity, with an increase in the exposure time that is 
similar to the result acquired during the investigation 
of effect of GA on A375S2 human melanoma cells 
by Lo et al[27]. Various anticancer drugs cause MPP 
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Figure 7  Representative photomicrograph and scanning electron microscopic images of three independent experiments. A: Photomicrograph images of 
untreated and gallic acid (GA) treated HCT-15 cells. The arrow mark indicates cell death after GA treatment; B: Scanning electron microscopic images of untreated 
and GA treated HCT-15 cells. The arrow mark represents the rounding up of HCT-15 cells after GA treatment.
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fluctuations and induce death of cancer cells[24]. 
Furthermore, the changes identified in the level of MPP 
in may be related to its inhibitory effect of GA against 
HCT-15 cells. Some recently concluded researches 
utilized Yo-Pro-1 as an effective agent in confirming 
apoptosis. The Yo-Pro-1 staining used to detect 
apoptosis induced by anticancer agents as it analyses 
the apoptotic cells without interfering cell viability[14]. 
Apart from the early and later events indicating the 
occurrence of apoptosis, Yo-pro-1 staining confirmed 
the apoptosis after GA treatment. 
Although apoptosis is confirmed by Yo-Pro-1 
staining it would be more interesting to study the 
various pro-apoptotic and anti-apoptotic protein level 
in GA treated HCT-15 cells. The analysis of cyclin/
CDK, p53, Bax, Bad, Bcl-2 and Bcl-xL protein levels at 
different time intervals would give more information 
regarding the apoptosis induced by GA. Hence in future 
research, this interesting points will be addressed. 
However, further development of this research work 
would be in vivo experimentation with GA. This would 
need a proper understanding of the degree to which 
GA is absorbed or becomes available at the site of 
physiological activity after administration. As the half-
maximal inhibitory concentration of GA obtained in our 
studies lies within the range of biological availability, 
the in vivo experimentation can be preceded. 
Nevertheless, proper experimentation using humans 
with risk of colon cancer in a larger group may validate 
the anticancer activity of GA more precisely. 
In conclusion, the phenolic compound GA inhibited 
the growth of HCT-15 colon cancer cells. GA exhibited 
antiproliferative effect on both colon cancer cell lines 
along with notable morphological and biochemical 
changes. The anti-cancerous effect of GA followed 
ROS dependent apoptosis in HCT-15 colon cancer 
cell lines. Early events associated with apoptosis like 
lipid layer breakage and fall in MPP were induced 
by GA treatment. The cell cycle progression was 
arrested at the sub-G1 phase by GA treatment. 
Morphological changes like membrane blebbing and 
shrinkage in the GA treated cells was depicted by 
SEM and photomicrograph images. In conclusion, GA 
induced apoptosis in HCT-15 cells through the ROS - 
mitochondrial pathway in a time dependent manner. 
These results propel the role of GA as a possible 
anticancer agent. However, further experiments in 
preclinical and clinical settings are needed to promote 
GA as a likely candidate for chemotherapy of colon 
cancer.
COMMENTS
Background
Many surveys have shown that all types of cancers have a link with the diets 
the authors consume. Especially, in the case of colon cancer, diet plays a 
crucial role as the colonic epithelial cells are exposed to diets directly. Because 
of this reason, scientists explore various natural compounds present in food 
substances to treat colon cancer. Some studies have already shown that these 
natural compounds are absorbed by the body and have the potential to reduce 
the risk of colon cancer. The current study deals with examining the growth 
inhibitory effect of the dietary phenolic phytochemical gallic acid (GA) against 
HCT-15 colon cancer cells. 
Research frontiers
Despite the several anticancer drugs that are available for colon cancer, 
scientists continuously search for a novel anticancer drug with enhanced 
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Figure 8  Apoptosis assessment using Yo-Pro-1 dye by flow cytometry. 
HCT-15 cells was treated with gallic acid (GA) for specified time points. 
The distribution of the cell population changed according to the exposure 
time as indicated by M1 and M2. Data represented is the maximum of three 
independent experiments and the differences in the values of M2 were 
significant at 48 h and 72 h compared to untreated control cells (P < 0.05 vs 
untreated control cells).
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efficacy. Previous experiments have investigated the anticancer effect of GA 
against colon cancer, while the various reactions induced by GA on colon 
cancer cells have never been examined.
Innovations and breakthroughs
The study emphasizes the mechanism related to the anticancer effect of GA 
against colon cancer cell. GA was found to inhibit the growth of colon cancer 
cells through reactive oxygen species (ROS)-mediated apoptosis with notable 
morphological changes. 
Applications
A series of events associated with the anticancer activity of GA are clearly 
depicted. Moreover, in-depth experimentation in preclinical and clinical settings 
is needed to promote GA as a plausible candidate for chemotherapy of colon 
cancer. Further, an in-depth proteomics study in relation to the GA induced 
apoptosis would be of great interest.
Terminology
Apoptosis or programmed cell death, the death of cells that occurs as a normal 
and controlled part of an organism’s growth or development which can be 
Apoptosis can be induced either by a stimulus, such as irradiation or toxic 
drugs, or by removal of a repressor agent.
Peer-review
Phytochemicals modulate key cellular signaling pathways and have proven 
anticancer effects. In the past, a large number of substances derived from 
plants have been studied in antitumor research fields and many have proven 
to exhibit chemopreventive properties which could be used as adjuvant 
chemotherapy. In this manuscript, the authors found that diet-derived phenolic 
compound GA inhibited the proliferation and induced the apoptosis of HCT-15 
cancer cells through increased generation of ROS. The study is important and 
may advance the field of chemoprevention.
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